SCHEMBL5657325

SCHEMBL5657325

OCCN1CCN(Cc2nonc2C(=Nc2ccc(F)c(Cl)c2)NO)CC1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 20/20 0.58
TDO2 P48775 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5630345 0.89 IDO1 (0.61) IDO1TDO2
SCHEMBL4986046 0.89 IDO1 (0.60) IDO1TDO2
SCHEMBL5632110 0.87 IDO1 (0.58) IDO1TDO2
SCHEMBL5631279 0.86 IDO1 (0.55) IDO1TDO2
SCHEMBL5630694 0.85 IDO1 (0.58) IDO1TDO2
SCHEMBL15093228 0.85 IDO1 (0.60) IDO1TDO2
SCHEMBL5631485 0.83 IDO1 (0.59) IDO1TDO2
SCHEMBL5629922 0.83 IDO1 (0.71) IDO1TDO2
SCHEMBL5633141 0.82 IDO1 (0.57) IDO1TDO2
SCHEMBL5631520 0.82 IDO1 (0.64) IDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION 2007-08-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase IDO1, IDO2, HNMT IDO1 1/4885TDO2 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.